On this episode Mike, Morgan, and Melissa explore how psychedelics like psilocybin, ketamine, and MDMA are being studied for mental health treatment. With the recent rise of accessabilty and micro-dosing, the discussion highlights the need for more research to better understand these therapies. They discuss the possible benefits, as well as risks, and why professional guidance and harm reduction are important.

Resources & Links:

Website: JAMA Psychiatry (Article: Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder)

Website: Nature Medicine (Article: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study)

Website: eClinical Medicine (Article: Ketamine for the treatment of major depression: a systematic review and meta-analysis)

Website: Psymposia (Article: How Silicon Valley Used Veterans to Hijack the Psychedelic Industry)

Website: Chacruna (Institute for Psychedelic Plant Medicines)

Search: The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma

______________________

If you or someone you know is struggling or in crisis, help is available. 988 Website

Mike and Morgan welcome questions and comments Email: A PsychoDelicous Conversation

Related Podcast: Mike & Morgan on Behind the Connection

Mike Stratton's A Groove Supreme

Spotify: Mike's Podcast, The Little Green Book